A detailed history of Ronald Blue Trust, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,182 shares of OGN stock, worth $18,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,182
Previous 7,599 84.45%
Holding current value
$18,391
Previous $113,000 84.96%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$14.44 - $18.83 $92,661 - $120,832
-6,417 Reduced 84.45%
1,182 $17,000
Q4 2024

Jan 22, 2025

BUY
$14.44 - $18.83 $56,864 - $74,152
3,938 Added 107.57%
7,599 $113,000
Q3 2024

Oct 17, 2024

BUY
$18.65 - $23.03 $46,774 - $57,759
2,508 Added 217.52%
3,661 $70,000
Q2 2024

Jul 18, 2024

BUY
$17.45 - $21.96 $10,312 - $12,978
591 Added 105.16%
1,153 $23,000
Q1 2024

May 01, 2024

SELL
$13.78 - $18.8 $19,099 - $26,056
-1,386 Reduced 71.15%
562 $10,000
Q4 2023

Jan 18, 2024

BUY
$10.95 - $17.32 $6,110 - $9,664
558 Added 40.14%
1,948 $34,000
Q3 2023

Oct 11, 2023

BUY
$16.59 - $23.77 $8,394 - $12,027
506 Added 57.24%
1,390 $29,000
Q2 2023

Jul 14, 2023

SELL
$19.27 - $24.63 $2,196 - $2,807
-114 Reduced 11.42%
884 $21,000
Q1 2023

Apr 17, 2023

BUY
$21.42 - $32.08 $1,756 - $2,630
82 Added 8.95%
998 $28,000
Q4 2022

Jan 17, 2023

BUY
$23.31 - $28.61 $6,223 - $7,638
267 Added 41.14%
916 $22,000
Q3 2022

Oct 21, 2022

BUY
$23.4 - $34.25 $93 - $137
4 Added 0.62%
649 $22,000
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $20,420 - $25,090
645 New
645 $23,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.